Maternal and Neonatal Herpes Simplex Virus Infections

Abstract

Genital herpes infections are extremely common worldwide and ∼22% of pregnant women are infected with herpes simplex virus. Eighty percent of those affected with genital herpes are unaware of being infected. The most devastating consequence of maternal genital herpes is neonatal herpes disease. Fortunately, neonatal herpes simplex infections are uncommon but due to the morbidity and mortality associated with the infection are often considered in the differential diagnosis of ill neonates. The use of polymerase chain reaction assay for diagnosis of central nervous system infections and the development of safe and effective antiviral therapy have revolutionized the diagnosis and management of these infants. Most recently, the initiation of long-term antiviral suppressive therapy in these infants has led to significant improvement in morbidity. This review will summarize the epidemiology of maternal and neonatal herpes infections and discuss clinical presentation, diagnosis, management, and follow-up of infants with neonatal herpes disease.

Keywords

genital herpes - neonatal herpes - acyclovir - PCR - antiviral therapy

• References

• 1 Centers for Disease Control and Prevention (CDC). Seroprevalence of herpes simplex virus type 2 among persons aged 14–49 years—United States, 2005–2008. MMWR Morb Mortal Wkly Rep 2010; 59: 456-459
• 2 Fleming DT, McQuillan GM, Johnson RE , et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997; 337: 1105-1111
• 3 Bryson Y, Dillon M, Bernstein DI, Radolf J, Zakowski P, Garratty E. Risk of acquisition of genital herpes simplex virus type 2 in sex partners of persons with genital herpes: a prospective couple study. J Infect Dis 1993; 167: 942-946
• 4 Ashley RL, Wald A. Genital herpes: review of the epidemic and potential use of type-specific serology. Clin Microbiol Rev 1999; 12: 1-8
• 5 Johnson RE, Nahmias AJ, Magder LS, Lee FK, Brooks CA, Snowden CB. A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States. N Engl J Med 1989; 321: 7-12
• 6 Mertz GJ, Schmidt O, Jourden JL , et al. Frequency of acquisition of first-episode genital infection with herpes simplex virus from symptomatic and asymptomatic source contacts. Sex Transm Dis 1985; 12: 33-39
• 7 Mertz GJ, Coombs RW, Ashley R , et al. Transmission of genital herpes in couples with one symptomatic and one asymptomatic partner: a prospective study. J Infect Dis 1988; 157: 1169-1177
• 8 Mertz GJ, Benedetti J, Ashley R, Selke SA, Corey L. Risk factors for the sexual transmission of genital herpes. Ann Intern Med 1992; 116: 197-202
• 9 Langenberg AG, Corey L, Ashley RL, Leong WP, Straus SE. Chiron HSV Vaccine Study Group. A prospective study of new infections with herpes simplex virus type 1 and type 2. N Engl J Med 1999; 341: 1432-1438
• 10 Wald A, Zeh J, Selke S , et al. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med 2000; 342: 844-850
• 11 Fife KH, Bernstein DI, Tu W , et al. Predictors of herpes simplex virus type 2 antibody positivity among persons with no history of genital herpes. Sex Transm Dis 2004; 31: 676-681
• 12 Lafferty WE, Downey L, Celum C, Wald A. Herpes simplex virus type 1 as a cause of genital herpes: impact on surveillance and prevention. J Infect Dis 2000; 181: 1454-1457
• 13 Roberts CM, Pfister JR, Spear SJ. Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students. Sex Transm Dis 2003; 30: 797-800
• 14 Kimberlin DW, Rouse DJ. Clinical practice. Genital herpes. N Engl J Med 2004; 350: 1970-1977
• 15 Engelberg R, Carrell D, Krantz E, Corey L, Wald A. Natural history of genital herpes simplex virus type 1 infection. Sex Transm Dis 2003; 30: 174-177
• 16 Kulhanjian JA, Soroush V, Au DS , et al. Identification of women at unsuspected risk of primary infection with herpes simplex virus type 2 during pregnancy. N Engl J Med 1992; 326: 916-920
• 17 Brown ZA, Selke S, Zeh J , et al. The acquisition of herpes simplex virus during pregnancy. N Engl J Med 1997; 337: 509-515
• 18 Whitley RJ, Nahmias AJ, Visintine AM, Fleming CL, Alford CA. The natural history of herpes simplex virus infection of mother and newborn. Pediatrics 1980; 66: 489-494
• 19 Whitley RJ, Corey L, Arvin A , et al. Changing presentation of herpes simplex virus infection in neonates. J Infect Dis 1988; 158: 109-116
• 20 Brown ZA, Benedetti J, Ashley R , et al. Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. N Engl J Med 1991; 324: 1247-1252
• 21 Arvin AM, Hensleigh PA, Prober CG , et al. Failure of antepartum maternal cultures to predict the infant's risk of exposure to herpes simplex virus at delivery. N Engl J Med 1986; 315: 796-800
• 22 Vontver LA, Hickok DE, Brown Z, Reid L, Corey L. Recurrent genital herpes simplex virus infection in pregnancy: infant outcome and frequency of asymptomatic recurrences. Am J Obstet Gynecol 1982; 143: 75-84
• 23 Workowski KA, Berman S. Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 2010; 59 (RR-12) 1-110
• 24 Sullender WM, Yasukawa LL, Schwartz M , et al. Type-specific antibodies to herpes simplex virus type 2 (HSV-2) glycoprotein G in pregnant women, infants exposed to maternal HSV-2 infection at delivery, and infants with neonatal herpes. J Infect Dis 1988; 157: 164-171
• 25 ACOG Committee on Practice Bulletins. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. No. 82 June 2007. Management of herpes in pregnancy. Obstet Gynecol 2007; 109: 1489-1498
• 26 Brown ZA, Wald A, Morrow RA, Selke S, Zeh J, Corey L. Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA 2003; 289: 203-209
• 27 Kimberlin DW. Neonatal herpes simplex infection. Clin Microbiol Rev 2004; 17: 1-13
• 28 Corey L, Wald A. Maternal and neonatal herpes simplex virus infections. N Engl J Med 2009; 361: 1376-1385
• 29 Nahmias AJ, Josey WE, Naib ZM, Freeman MG, Fernandez RJ, Wheeler JH. Perinatal risk associated with maternal genital herpes simplex virus infection. Am J Obstet Gynecol 1971; 110: 825-837
• 30 Prober CG, Sullender WM, Yasukawa LL, Au DS, Yeager AS, Arvin AM. Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes simplex virus infections. N Engl J Med 1987; 316: 240-244
• 31 Yeager AS, Arvin AM. Reasons for the absence of a history of recurrent genital infections in mothers of neonates infected with herpes simplex virus. Pediatrics 1984; 73: 188-193
• 32 Peng J, Krause PJ, Kresch M. Neonatal herpes simplex virus infection after cesarean section with intact amniotic membranes. J Perinatol 1996; 16: 397-399
• 33 O'Riordan DP, Golden WC, Aucott SW. Herpes simplex virus infections in preterm infants. Pediatrics 2006; 118: e1612-e1620
• 34 Overall Jr JC. Herpes simplex virus infection of the fetus and newborn. Pediatr Ann 1994; 23: 131-136
• 35 Whitley RJ, Nahmias AJ, Soong SJ, Galasso GG, Fleming CL, Alford CA. Vidarabine therapy of neonatal herpes simplex virus infection. Pediatrics 1980; 66: 495-501
• 36 Whitley R, Arvin A, Prober C , et al; Infectious Diseases Collaborative Antiviral Study Group. A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. N Engl J Med 1991; 324: 444-449
• 37 Whitley R, Arvin A, Prober C , et al; The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Predictors of morbidity and mortality in neonates with herpes simplex virus infections. N Engl J Med 1991; 324: 450-454
• 38 Kimberlin DW, Lin CY, Jacobs RF , et al; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics 2001; 108: 230-238
• 39 Kimberlin DW, Lin CY, Jacobs RF , et al; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics 2001; 108: 223-229
• 40 Arvin AM, Yeager AS, Bruhn FW, Grossman M. Neonatal herpes simplex infection in the absence of mucocutaneous lesions. J Pediatr 1982; 100: 715-721
• 41 Pickering L, Baker C, Kimberlin D. In: Pickering L, , ed. Red Book Report of the Committee on Infectious Diseases. 29th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2012: 398-408
• 42 Barbi M, Binda S, Primache V, Tettamanti A, Negri C, Brambilla C. Use of Guthrie cards for the early diagnosis of neonatal herpes simplex virus disease. Pediatr Infect Dis J 1998; 17: 251-252
• 43 Diamond C, Mohan K, Hobson A, Frenkel L, Corey L. Viremia in neonatal herpes simplex virus infections. Pediatr Infect Dis J 1999; 18: 487-489
• 44 Kimberlin DW, Lakeman FD, Arvin AM , et al; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus disease. J Infect Dis 1996; 174: 1162-1167
• 45 Malm G, Forsgren M. Neonatal herpes simplex virus infections: HSV DNA in cerebrospinal fluid and serum. Arch Dis Child Fetal Neonatal Ed 1999; 81: F24-F29
• 46 Atkins JT. HSV PCR for CNS infections: pearls and pitfalls. Pediatr Infect Dis J 1999; 18: 823-824
• 47 Kimura H, Futamura M, Kito H , et al. Detection of viral DNA in neonatal herpes simplex virus infections: frequent and prolonged presence in serum and cerebrospinal fluid. J Infect Dis 1991; 164: 289-293
• 48 Troendle-Atkins J, Demmler GJ, Buffone GJ. Rapid diagnosis of herpes simplex virus encephalitis by using the polymerase chain reaction. J Pediatr 1993; 123: 376-380
• 49 Englund JA, Fletcher CV, Balfour Jr HH. Acyclovir therapy in neonates. J Pediatr 1991; 119 (1 Pt 1) 129-135
• 50 Caviness AC, Demmler GJ, Almendarez Y, Selwyn BJ. The prevalence of neonatal herpes simplex virus infection compared with serious bacterial illness in hospitalized neonates. J Pediatr 2008; 153: 164-169
• 51 Kimberlin DW. When should you initiate acyclovir therapy in a neonate?. J Pediatr 2008; 153: 155-156
• 52 Long SS. In defense of empiric acyclovir therapy in certain neonates. J Pediatr 2008; 153: 157-158
• 53 Kimberlin DW, Whitley RJ, Wan W , et al; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Oral acyclovir suppression and neurodevelopment after neonatal herpes. N Engl J Med 2011; 365: 1284-1292
• 54 Kimberlin D, Powell D, Gruber W , et al. Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a phase I/II trial. Pediatr Infect Dis J 1996; 15: 247-254
• 55 Kimberlin DW, Jacobs RF, Weller S , et al. Pharmacokinetics and safety of extemporaneously compounded valacyclovir oral suspension in pediatric patients from 1 month through 11 years of age. Clin Infect Dis 2010; 50: 221-228
• 56 Pinninti SG, Angara R, Feja KN , et al. Neonatal herpes disease following maternal antenatal antiviral suppressive therapy: a multicenter case series. J Pediatr 2012; 161: 134-138 , e1–e3
• 57 Stanberry LR, Spruance SL, Cunningham AL , et al; GlaxoSmithKline Herpes Vaccine Efficacy Study Group. Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N Engl J Med 2002; 347: 1652-1661
• 58 Belshe RB, Leone PA, Bernstein DI , et al; Herpevac Trial for Women. Efficacy results of a trial of a herpes simplex vaccine. N Engl J Med 2012; 366: 34-43
• 59 Whitley RJ, Kimberlin DW. Treatment of viral infections during pregnancy and the neonatal period. Clin Perinatol 1997; 24: 267-283